annual cash & cash equivalents:
$311.30M-$238.90M(-43.42%)Summary
- As of today (June 19, 2025), DBD annual cash & cash equivalents is $311.30 million, with the most recent change of -$238.90 million (-43.42%) on December 31, 2024.
- During the last 3 years, DBD annual cash & cash equivalents has fallen by -$77.60 million (-19.95%).
- DBD annual cash & cash equivalents is now -52.31% below its all-time high of $652.70 million, reached on December 31, 2016.
Performance
DBD Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$306.50M+$10.30M(+3.48%)Summary
- As of today (June 19, 2025), DBD quarterly cash & cash equivalents is $306.50 million, with the most recent change of +$10.30 million (+3.48%) on March 31, 2025.
- Over the past year, DBD quarterly cash & cash equivalents has increased by +$24.60 million (+8.73%).
- DBD quarterly cash & cash equivalents is now -59.04% below its all-time high of $748.20 million, reached on September 30, 2016.
Performance
DBD quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DBD Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -43.4% | +8.7% |
3 y3 years | -19.9% | +36.4% |
5 y5 years | +10.8% | -40.1% |
DBD Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.4% | +1.3% | -44.3% | +138.7% |
5 y | 5-year | -43.4% | +10.8% | -44.3% | +138.7% |
alltime | all time | -52.3% | +1882.8% | -59.0% | +1852.2% |
DBD Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $306.50M(+3.5%) |
Dec 2024 | $311.30M(-43.4%) | $296.20M(+18.0%) |
Sep 2024 | - | $251.10M(-9.3%) |
Jun 2024 | - | $276.70M(-1.8%) |
Mar 2024 | - | $281.90M(-48.8%) |
Dec 2023 | $550.20M(+79.0%) | $550.20M(+46.3%) |
Sep 2023 | - | $376.10M(-30.6%) |
Jun 2023 | - | $541.80M(+119.9%) |
Mar 2023 | - | $246.40M(-19.8%) |
Dec 2022 | $307.40M(-21.0%) | $307.40M(+139.4%) |
Sep 2022 | - | $128.40M(-48.6%) |
Jun 2022 | - | $249.90M(+11.2%) |
Mar 2022 | - | $224.70M(-42.2%) |
Dec 2021 | $388.90M(+19.8%) | $388.90M(+80.1%) |
Sep 2021 | - | $215.90M(-3.7%) |
Jun 2021 | - | $224.30M(-4.5%) |
Mar 2021 | - | $234.80M(-27.6%) |
Dec 2020 | $324.50M(+15.5%) | $324.50M(+18.6%) |
Sep 2020 | - | $273.70M(-38.7%) |
Jun 2020 | - | $446.40M(-12.8%) |
Mar 2020 | - | $512.10M(+82.3%) |
Dec 2019 | $280.90M(-38.7%) | $280.90M(+11.3%) |
Sep 2019 | - | $252.30M(-2.9%) |
Jun 2019 | - | $259.80M(-31.3%) |
Mar 2019 | - | $377.90M(-17.6%) |
Dec 2018 | $458.40M(-15.6%) | $458.40M(+50.6%) |
Sep 2018 | - | $304.40M(+1.8%) |
Jun 2018 | - | $299.00M(-17.4%) |
Mar 2018 | - | $362.10M(-33.3%) |
Dec 2017 | $543.20M(-16.8%) | $543.20M(+42.7%) |
Sep 2017 | - | $380.70M(-15.6%) |
Jun 2017 | - | $451.30M(-7.9%) |
Mar 2017 | - | $490.10M(-24.9%) |
Dec 2016 | $652.70M(+108.1%) | $652.70M(-12.8%) |
Sep 2016 | - | $748.20M(+123.0%) |
Jun 2016 | - | $335.50M(+10.1%) |
Mar 2016 | - | $304.60M(-2.9%) |
Dec 2015 | $313.60M(-3.8%) | $313.60M(+58.0%) |
Sep 2015 | - | $198.50M(-18.8%) |
Jun 2015 | - | $244.40M(+7.6%) |
Mar 2015 | - | $227.10M(-30.4%) |
Dec 2014 | $326.10M(+41.3%) | $326.10M(+35.6%) |
Sep 2014 | - | $240.43M(+7.9%) |
Jun 2014 | - | $222.86M(+2.6%) |
Mar 2014 | - | $217.20M(-5.9%) |
Dec 2013 | $230.71M(-37.4%) | $230.71M(+12.0%) |
Sep 2013 | - | $205.92M(-27.1%) |
Jun 2013 | - | $282.57M(-16.9%) |
Mar 2013 | - | $340.14M(-7.8%) |
Dec 2012 | $368.79M(+10.4%) | $368.79M(+21.9%) |
Sep 2012 | - | $302.55M(-5.6%) |
Jun 2012 | - | $320.54M(+2.9%) |
Mar 2012 | - | $311.44M(-6.7%) |
Dec 2011 | $333.92M(+1.6%) | $333.92M(+30.0%) |
Sep 2011 | - | $256.81M(-7.9%) |
Jun 2011 | - | $278.74M(-0.3%) |
Mar 2011 | - | $279.56M(-14.9%) |
Dec 2010 | $328.66M(+0.1%) | $328.66M(+37.0%) |
Sep 2010 | - | $239.82M(+3.5%) |
Jun 2010 | - | $231.62M(-12.9%) |
Mar 2010 | - | $265.87M(-19.0%) |
Dec 2009 | $328.43M(+36.0%) | $328.43M(+62.0%) |
Sep 2009 | - | $202.76M(-1.7%) |
Jun 2009 | - | $206.21M(-7.0%) |
Mar 2009 | - | $221.75M(-8.2%) |
Dec 2008 | $241.44M(+17.0%) | $241.44M(+13.5%) |
Sep 2008 | - | $212.78M(+22.1%) |
Jun 2008 | - | $174.24M(+22.7%) |
Mar 2008 | - | $142.01M(-31.2%) |
Dec 2007 | $206.33M(-18.8%) | $206.33M(+45.6%) |
Sep 2007 | - | $141.75M(+5.9%) |
Jun 2007 | - | $133.80M(+41.9%) |
Mar 2007 | - | $94.30M(-62.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2006 | $253.97M(+22.2%) | $253.97M(+20.8%) |
Sep 2006 | - | $210.16M(+31.9%) |
Jun 2006 | - | $159.37M(-48.8%) |
Mar 2006 | - | $311.31M(+49.7%) |
Dec 2005 | $207.90M(+13.0%) | $207.90M(+21.1%) |
Sep 2005 | - | $171.64M(+19.9%) |
Jun 2005 | - | $143.17M(-6.7%) |
Mar 2005 | - | $153.40M(-16.7%) |
Dec 2004 | $184.04M(+8.3%) | $184.04M(+81.4%) |
Sep 2004 | - | $101.45M(-17.7%) |
Jun 2004 | - | $123.31M(-15.9%) |
Mar 2004 | - | $146.61M(-13.7%) |
Dec 2003 | $169.95M(+9.3%) | $169.95M(+62.3%) |
Sep 2003 | - | $104.73M(-13.1%) |
Jun 2003 | - | $120.50M(-13.2%) |
Mar 2003 | - | $138.75M(-10.7%) |
Dec 2002 | $155.45M(+110.7%) | $155.45M(+82.1%) |
Sep 2002 | - | $85.36M(+26.6%) |
Jun 2002 | - | $67.43M(+3.2%) |
Mar 2002 | - | $65.35M(-11.4%) |
Dec 2001 | $73.77M(+13.2%) | $73.77M(+109.0%) |
Sep 2001 | - | $35.29M(+1.1%) |
Jun 2001 | - | $34.93M(-31.3%) |
Mar 2001 | - | $50.87M(-22.0%) |
Dec 2000 | $65.18M(+138.8%) | $65.18M(+15.9%) |
Sep 2000 | - | $56.25M(+47.9%) |
Jun 2000 | - | $38.03M(-34.4%) |
Mar 2000 | - | $57.98M(+112.4%) |
Dec 1999 | $27.30M(-35.8%) | $27.30M(+62.5%) |
Sep 1999 | - | $16.80M(-22.9%) |
Jun 1999 | - | $21.80M(-51.8%) |
Mar 1999 | - | $45.20M(+6.4%) |
Dec 1998 | $42.50M(+109.4%) | $42.50M(+20.4%) |
Sep 1998 | - | $35.30M(+46.5%) |
Jun 1998 | - | $24.10M(-21.2%) |
Mar 1998 | - | $30.60M(+50.7%) |
Dec 1997 | $20.30M(-7.3%) | $20.30M(-31.9%) |
Sep 1997 | - | $29.80M(+24.7%) |
Jun 1997 | - | $23.90M(-28.9%) |
Mar 1997 | - | $33.60M(+53.4%) |
Dec 1996 | $21.90M(+39.5%) | $21.90M(-16.4%) |
Sep 1996 | - | $26.20M(-2.6%) |
Jun 1996 | - | $26.90M(-24.6%) |
Mar 1996 | - | $35.70M(+127.4%) |
Dec 1995 | $15.70M(-9.2%) | $15.70M(-63.2%) |
Sep 1995 | - | $42.70M(-27.6%) |
Jun 1995 | - | $59.00M(-11.3%) |
Mar 1995 | - | $66.50M(+284.4%) |
Dec 1994 | $17.30M(-55.6%) | $17.30M(-24.1%) |
Sep 1994 | - | $22.80M(-2.1%) |
Jun 1994 | - | $23.30M(-44.5%) |
Mar 1994 | - | $42.00M(+7.7%) |
Dec 1993 | $39.00M(+13.4%) | $39.00M(+62.5%) |
Sep 1993 | - | $24.00M(-3.6%) |
Jun 1993 | - | $24.90M(-38.1%) |
Mar 1993 | - | $40.20M(+16.9%) |
Dec 1992 | $34.40M(+14.7%) | $34.40M(-15.7%) |
Sep 1992 | - | $40.80M(+30.4%) |
Jun 1992 | - | $31.30M(+1.6%) |
Mar 1992 | - | $30.80M(+2.7%) |
Dec 1991 | $30.00M(-10.7%) | $30.00M(+23.0%) |
Sep 1991 | - | $24.40M(-21.3%) |
Jun 1991 | - | $31.00M(+21.1%) |
Mar 1991 | - | $25.60M(-23.8%) |
Dec 1990 | $33.60M(-7.9%) | $33.60M(+22.6%) |
Sep 1990 | - | $27.40M(-7.4%) |
Jun 1990 | - | $29.60M(-14.0%) |
Mar 1990 | - | $34.40M(-5.8%) |
Dec 1989 | $36.50M(-60.2%) | $36.50M(-60.2%) |
Dec 1988 | $91.60M(+8.8%) | $91.60M(+8.8%) |
Dec 1987 | $84.20M(+2.9%) | $84.20M(+2.9%) |
Dec 1986 | $81.80M(-19.4%) | $81.80M(-19.4%) |
Dec 1985 | $101.50M(+31.3%) | $101.50M(+31.3%) |
Dec 1984 | $77.30M | $77.30M |
FAQ
- What is Diebold Nixdorf Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Diebold Nixdorf Incorporated?
- What is Diebold Nixdorf Incorporated annual cash & cash equivalents year-on-year change?
- What is Diebold Nixdorf Incorporated quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Diebold Nixdorf Incorporated?
- What is Diebold Nixdorf Incorporated quarterly cash & cash equivalents year-on-year change?
What is Diebold Nixdorf Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of DBD is $311.30M
What is the all time high annual cash & cash equivalents for Diebold Nixdorf Incorporated?
Diebold Nixdorf Incorporated all-time high annual cash & cash equivalents is $652.70M
What is Diebold Nixdorf Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, DBD annual cash & cash equivalents has changed by -$238.90M (-43.42%)
What is Diebold Nixdorf Incorporated quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DBD is $306.50M
What is the all time high quarterly cash & cash equivalents for Diebold Nixdorf Incorporated?
Diebold Nixdorf Incorporated all-time high quarterly cash & cash equivalents is $748.20M
What is Diebold Nixdorf Incorporated quarterly cash & cash equivalents year-on-year change?
Over the past year, DBD quarterly cash & cash equivalents has changed by +$24.60M (+8.73%)